Skip to content

Ajoint Rheumatology

Active
Private limited companyfounded 2024active for 2 yearsDendermondse steenweg 184, 9300 Aalst, BelgiumKBO/BCE: BE 1014.711.852
Summary

Ajoint Rheumatology has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €56,820 and a net result of €56,179. Its solvency ranks better than 68% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 07-10-2024 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.365.516.729 9300 Aalst, since 07-10-2024
Financial year end
30 September
Peppol
Reachable since 13-12-2024

Board and ownership

Board

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€71,105
Turnover
≈ €160,000
estimated
Profit
€56,179
Equity
€56,820
Total assets
€72,440
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.48, cash €69,959Figures for financial year 2025 (filed on 22-04-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 80% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 100
equity 78.4% of total assets
Liquidity 93
short-term debt 21.6% · cash 96.6%
Profitability 100
return on assets 77.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 11-2025: 0.6% 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.7%▲ +0.1 percentage points vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.8%▲ +0.1 percentage points vs 05-2026 07-2026: 0.7%▼ -0.1 percentage points vs 06-2026 08-2026: 0.7%● unchanged vs 07-2026 09-2026: 0.8%▲ +0.1 percentage points vs 08-2026highest value 10-2026: < 0.1%▼ -0.8 percentage points vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.48, above the usual 1.5. Short-term debt is 21.6% and cash 96.6% of total assets. 21.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 79% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.48, cash €69,959
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed on 22-04-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 22-04-2026, 8 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
8 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Recent changes

  1. · Gazette deed Registered office moved within AalstNew seat: Dendermondse Steenweg 184, 9300 Aalst · Previous seat: Bert van Hoorickstraat 39/32, 9300 Aalst
  2. · Gazette deed IncorporationStarting capital €1,500 · Appointment: LIEVENS Charlotte (statutory director)
All 3 events

Comparable companies

These companies have the same main activity as Ajoint Rheumatology: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €66,500 and €78,600, founded in 2024.

CompanyTotal assetsGross margin
Ajoint Rheumatology Aalst€72,440€71,105
CLASON Wetteren€77,804€69,104
DR. LD INTERNIST-ENDOCRINOLOOG Merelbeke-Melle€66,477€67,461
Jasmin Verbist Holsbeek€78,157€72,150
BOURGUIGNON - UROLOGIE Fosses-la-Ville€67,655€68,174
OFTOMAT Antwerpen€69,107€66,232
DR. AD ANESTHESIE Turnhout€78,611€69,340
Full comparison

Key facts about Ajoint Rheumatology

What is the company number of Ajoint Rheumatology?
The company number of Ajoint Rheumatology is 1014.711.852. The VAT number is the same number with BE in front: BE 1014.711.852.
Where is Ajoint Rheumatology based?
The registered office is at Dendermondse steenweg 184, 9300 Aalst.Company details
What does Ajoint Rheumatology do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Ajoint Rheumatology?
The legal form of Ajoint Rheumatology is Private limited company (BV).
When was Ajoint Rheumatology founded?
Ajoint Rheumatology was founded on 07-10-2024.
Is Ajoint Rheumatology still active?
Yes, Ajoint Rheumatology is an active enterprise in the KBO register.
What is the turnover of Ajoint Rheumatology?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €71,105 and 32 comparable companies (NACE 862). It probably lies between €120,000 and €210,000.Financials
Is Ajoint Rheumatology profitable?
In financial year 2025, Ajoint Rheumatology made a profit of €56,179.
Where can I find the annual accounts of Ajoint Rheumatology?
Ajoint Rheumatology filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.